US OptionsDetailed Quotes
OCGN241220P1000
- 0.15
- -0.04-21.05%
15min DelayClose Nov 22 16:00 ET
0.15High0.15Low
0.15Open0.19Pre Close19 Volume619 Open Interest1.00Strike Price285.00Turnover147.63%IV6.28%PremiumDec 20, 2024Expiry Date0.09Intrinsic Value100Multiplier27DDays to Expiry0.06Extrinsic Value100Contract SizeAmericanOptions Type-0.5144Delta1.1004Gamma4.54Leverage Ratio-0.0027Theta-0.0004Rho-2.33Eff Leverage0.0010Vega
Ocugen Stock Discussion
Sign in to post a comment
$Ocugen (OCGN.US)$ buy dont sell
1
$Ocugen (OCGN.US)$ Reuters· 3 mins ago
Ocugen Announces European Medicines Agency Grants Orphan Medicinal Product Designation for Modifier Gene Therapy Candidate Ocu410St for Treatment of Abca4-Associated Retinopathies Including Stargardt Disease
Ocugen Announces European Medicines Agency Grants Orphan Medicinal Product Designation for Modifier Gene Therapy Candidate Ocu410St for Treatment of Abca4-Associated Retinopathies Including Stargardt Disease
1
$Ocugen (OCGN.US)$ Reuters· just
Ocugen Announces Compelling Preliminary Data for Ocu410—a Single Dose Novel Modifier Gene Therapy to Treat Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
Ocugen Announces Compelling Preliminary Data for Ocu410—a Single Dose Novel Modifier Gene Therapy to Treat Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
1
1
$Ocugen (OCGN.US)$ it exceeded estimates for these few quarters
$Ocugen (OCGN.US)$ price manipulation
$Ocugen (OCGN.US)$ no sell button
1
$Ocugen (OCGN.US)$ let's goooo
2
No comment yet
GERMAN APE OP : Great News!